financetom
Business
financetom
/
Business
/
Castle Biosciences Insider Sold Shares Worth $390,572, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Castle Biosciences Insider Sold Shares Worth $390,572, According to a Recent SEC Filing
Aug 29, 2025 1:30 PM

04:07 PM EDT, 08/29/2025 (MT Newswires) -- Kristen M Oelschlager, Chief Operating Officer, on August 27, 2025, sold 18,007 shares in Castle Biosciences ( CSTL ) for $390,572. Following the Form 4 filing with the SEC, Oelschlager has control over a total of 153,793 common shares of the company, with 153,793 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1447362/000185656525000006/xslF345X05/wk-form4_1756497844.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Latin America's oil leaders to outcompete Venezuela through 2030, Rystad says
Latin America's oil leaders to outcompete Venezuela through 2030, Rystad says
Mar 11, 2026
MEXICO CITY, Feb 4 (Reuters) - Argentina, Guyana and Brazil will lead Latin American oil production growth in 2026, adding ‌more than 700,000 barrels per day ​and outcompeting Venezuela through at least ‍2030, according to Rystad ⁠Energy analysis. KEY ⁠CONTEXT -- Latin America's oil production is ‌forecast to exceed ​8.8 million barrels per day this year, Rystad Energy ⁠said in...
India's Lupin Launches Seizure Drug Bioequivalent to Supernus Pharmaceuticals' Trokendi XR
India's Lupin Launches Seizure Drug Bioequivalent to Supernus Pharmaceuticals' Trokendi XR
Mar 11, 2026
02:45 PM EST, 02/04/2026 (MT Newswires) -- India-based pharmaceutical company Lupin said Wednesday it has launched a drug that is bioequivalent to Supernus Pharmaceuticals' ( SUPN ) Trokendi XR in the US. Lupin's Topiramate extended-release capsules were launched after the US Food and Drug Administration approved its Abbreviated New Drug Application, the company said. The drug is approved for partial-onset...
Commercial Metals Insider Sold Shares Worth $2,003,249, According to a Recent SEC Filing
Commercial Metals Insider Sold Shares Worth $2,003,249, According to a Recent SEC Filing
Mar 11, 2026
02:45 PM EST, 02/04/2026 (MT Newswires) -- Jennifer J Durbin, Former Chief Human Resources and Communications Officer, on February 03, 2026, sold 25,050 shares in Commercial Metals ( CMC ) for $2,003,249. Following the Form 4 filing with the SEC, Durbin has control over a total of 52,880 common shares of the company, with 52,880 shares held directly. SEC Filing:...
Standex International Insider Bought Shares Worth $490,000, According to a Recent SEC Filing
Standex International Insider Bought Shares Worth $490,000, According to a Recent SEC Filing
Mar 11, 2026
02:46 PM EST, 02/04/2026 (MT Newswires) -- Andy L Nemeth, Director, on February 04, 2026, executed a purchase for 2,000 shares in Standex International ( SXI ) for $490,000. Following the Form 4 filing with the SEC, Nemeth has control over a total of 8,639 common shares of the company, with 8,639 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/310354/000031035426000002/xslF345X05/form4.xml Price: 242.97,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved